Hims & Hers’ Compounded Semaglutide Pill Triggers US FDA Enforcement

Law concept
Hims & Hers is facing a DoJ investigation for semaglutide compounding. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Compliance

More from United States